Company intelligence
Abera Bioscience AB
A vaccine plattform company
Biotechnology Research
Uppsala, SE
11–50 employees
Founded 2012
1 public signals
About Abera Bioscience AB
Abera Bioscience AB is a Swedish biotech company headquartered in Uppsala. We are dedicated to develop novel mucosal vaccines based on proprietary vaccine platforms to improve health worldwide. Abera's platforms allows the development of efficient multivalent, multi-stage vaccines for oral and nasal administration. It also enables faster and more cost-effective production. Abera's OMV-based vaccines can be manufactured within 14-30 days.
Verified activity
Signals from Abera Bioscience AB
1 published signal